Product Overview
Emitino 8mg contains ondansetron, a 5-HT3 receptor antagonist used to prevent and treat:
- Chemotherapy-induced nausea/vomiting (CINV) (high/medium emetogenic chemo).
- Radiotherapy-induced nausea/vomiting.
- Post-operative nausea/vomiting (PONV) after surgery.
- Severe morning sickness (off-label, under strict supervision).
It works by blocking serotonin receptors in the gut and CNS, reducing vomiting signals. In Kenya, Emitino is a critical supportive care drug in oncology and surgical wards, available in hospitals and pharmacies.
Key Benefits:
- Rapid onset (30 mins IV/oral).
- Minimal sedation vs. older antiemetics (e.g., metoclopramide).
- First-line for CINV per Kenya National Cancer Treatment Guidelines.
Frequently Asked Questions (FAQs)
-
What is Emitino 8mg used for?
- Primary: Nausea/vomiting from chemotherapy, radiation, or surgery.
- Off-label: Severe hyperemesis gravidarum (pregnancy-related vomiting).
-
Is Emitino available in Kenya?
- Yes, stocked in:
- Oncology centers: Nairobi Hospital, Texas Cancer Center, MP Shah Hospital.
- Major pharmacies: Goodlife, Medsafes, Cintas Pharma.
- Government hospitals: Kenyatta National Hospital (KNH), Moi Teaching & Referral Hospital.
- Cost: ~KES 800–1,500 for 10 tablets; IV vials ~KES 2,000–3,000.
- Yes, stocked in:
-
Can I use it for motion sickness or general nausea?
- No. Emitino is reserved for severe cases (e.g., chemo). Use meclizine or dimenhydrinate for motion sickness.
-
What are the side effects?
- Common: Headache, constipation, dizziness.
- Serious (seek help):
- QT prolongation (irregular heartbeat – avoid if heart conditions).
- Serotonin syndrome (if combined with SSRIs/SNRIs).
- Severe allergic reaction (swelling, breathing trouble).
-
Is it safe during pregnancy?
- Category B (animal studies show no risk; human data limited). Use only if benefits outweigh risks (e.g., hyperemesis).
How to Use Emitino 8mg
-
Dosage (Adults):
- CINV:
- Oral: 8mg 30 mins before chemo, then 8mg every 8 hours for 1–2 days.
- IV: 8mg slow infusion over 15 mins pre-chemo.
- PONV: 16mg 1 hour before surgery.
- Max Daily Dose: 24mg (oral), 32mg (IV).
- CINV:
-
Administration:
- Oral: Swallow whole with water. Can be taken with/without food.
- IV: Only by healthcare professionals (slow infusion to prevent arrhythmias).
-
Missed Dose:
- Take if remembered soon. Skip if near next dose. Do not double.
-
Critical Precautions:
- Heart Conditions: Avoid if history of QT prolongation or heart failure.
- Liver Impairment: Max 8mg/day (reduced clearance).
- Drug Interactions: Avoid apomorphine, tramadol, SSRIs (e.g., fluoxetine).
Composition
- Active Ingredient: Ondansetron Hydrochloride Dihydrate (8mg per tablet/vial).
- Inactive Ingredients (Tablets): Lactose, microcrystalline cellulose, magnesium stearate.
- IV Solution: Sodium chloride, citric acid, water for injection.
- Packaging:
- Tablets: 10s blister pack.
- IV: 2ml/4ml vials (4mg/ml or 8mg/ml).
Conclusion
Emitino 8mg is a lifesaving antiemetic in Kenya’s cancer and surgical care, offering targeted relief from debilitating nausea/vomiting. Its efficacy in CINV makes it indispensable for chemotherapy patients, but cardiac safety must be prioritized (ECG monitoring for high-risk patients). For accessibility, generics (e.g., Ondem, Zofran) are equally effective and cheaper.
Access & Support in Kenya:
- NHIF Coverage:
- Fully covered under “Supa Cover” for cancer patients (chemo-related nausea).
- Submit oncologist’s prescription + chemo records.
- Cost-Saving Tips:
- Generics: Ask for Ondansetron 8mg (KES 400–800 for 10 tabs vs. Emitino’s KES 800–1,500).
- Hospitals: KNH and Moi Referral provide free Emitino to admitted chemo patients.
- Patient Support:
- Faraja Cancer Support: Offers free antiemetics to low-income patients.
- Kenya Hospices and Palliative Care Association (KEHPCA): Home-based nausea management.
Disclaimer: Not medical advice. Use only under medical supervision




Reviews
There are no reviews yet.